Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre‐transplant predictors of survival, reactivation, and spontaneous clearanceJulian Lindsay, Matthew Greenwood, Steven A. Pergam et al.|Transplant Infectious Disease|2020Cited by 16
SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell TransplantationJulian Lindsay, Monica A. Slavin, Jad Othman et al.|Open Forum Infectious Diseases|2021Cited by 15
Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATGJad Othman, David Gottlieb, Matthew Greenwood et al.|Biology of Blood and Marrow Transplantation|2020Cited by 14
Dynamics of Epstein–Barr virus on post‐transplant lymphoproliferative disorders after antithymocyte globulin‐conditioned allogeneic hematopoietic cell transplantJulian Lindsay, Monica A. Slavin, Jad Othman et al.|Transplant Infectious Disease|2021Cited by 12